The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Review: Neuropsychiatric involvement in pediatric systemic lupus erythematosus
Abstract
Neuropsychiatric (NP) manifestations are found in approximately 25% of children and adolescents with pediatric SLE (pSLE). In 70% of those, NP involvement will occur within the first year from the time of diagnosis. Headaches (66%), psychosis (36%), cognitive dysfunction (27%) and cerebrovascular disease (24%) are the most common presentations. The support of a psychiatrist is often required. Anti-phospholipid antibodies are associated with distinct NP disease entities and may be implicated in the pathogenesis of several manifestations of NP-pSLE including chorea, cerebrovascular disease and seizures. The role of novel auto-antibodies and imaging modalities is currently explored. The treatment of NP-pSLE is not based on prospective studies; however, an immunosuppressive combination therapy consisting of high doses of prednisone and a second line agent such as cyclophosphamide or azathioprine is commonly suggested for children with NP-pSLE. The role of novel therapies is currently studied. The outcome of children with NP-pSLE is relatively good. The overall survival is 95—97%, 20% of children experience a disease flare during childhood and 25% have evidence of permanent neuropsychiatric damage. Lupus (2007) 16, 564—571.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
COGNITIVE IMPAIRMENT AND AUTOANTLBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS
HANLY, J. G., WALSH, N. M., FISK, J. D., EASTWOOD, B., HONG, C., SHERWOOD, G., JONES, J. V., JONES, E., & ELKON, K. (1993) · Rheumatology · doi:10.1093/rheumatology/32.4.291 · Cited by 94
Cited by
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
van Vollenhoven, R. F., Mosca, M., Bertsias, G., Isenberg, D., Kuhn, A., Lerstrøm, K., Aringer, M., Bootsma, H., Boumpas, D., Bruce, I. N., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-205139 · Cited by 740
Systemic Lupus Erythematosus in Children and Adolescents
Levy, D. M., & Kamphuis, S. (2012) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2012.03.007 · Cited by 359
Mina, R., & Brunner, H. I. (2010) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2009.12.012 · Cited by 291
Overview of treatment of pediatric acute-onset neuropsychiatric syndrome
Swedo, S. E., Frankovich, J., & Murphy, T. K. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0042 · Cited by 104
Metadata
- Authors
- Benseler, S. M., & Silverman, E. D.
- Venue
- Lupus
- Publisher
- SAGE Publications
- Published
- 2007-08
- Volume
- 16
- Issue
- 8
- Pages
- 564-571
- ISSN
- 0961-2033 (ISSN-L)
- 1477-0962
- OpenAlex
- W1965306208
- Cited by
- 167
- References
- 1
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Review: Neuropsychiatric involvement in pediatric systemic lupus erythematosus. https://app.cochat.ai/papers/10.1177/0961203307078971
- The paper
- Benseler, S. M., & Silverman, E. D. (2007). Review: Neuropsychiatric involvement in pediatric systemic lupus erythematosus. Lupus. https://doi.org/10.1177/0961203307078971
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.